TAT-CBD3A6K acetate is a modified TAT-CBD3 peptide. It decreases T-type and R-type voltage-dependent calcium currents in dorsal root ganglion (DRG) neurons. By inhibiting CRMP-2 mediated enhancement of T-type and R-type calcium channel functions, TAT-CBD3A6K acetate demonstrates anti-nociception in a model of AIDS-induced peripheral neuropathy.
Target:
Calcium Channel
TP3240
* VAT and and shipping costs not included. Errors and price changes excepted